Showing results (401-410 of 731) with videos related to

Sort By:
Pageof 74
Inflammation and Regeneration|April 25, 2024
Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept studyKenji Suzuki, Yukinori Sameshima, Junji Yokoyama, et al.
Therapeutic Advances in Gastroenterology|October 7, 2021
Case report of severe constrictive perimyocarditis and ischemic hepatitis in a Crohn's disease patient upon infliximab-induced lupus-like syndromeSimon Hirschmann, Sarah Fischer, Entcho Klenske, et al.
International Journal of Molecular Sciences|February 26, 2022
Natural NADH and FAD Autofluorescence as Label-Free Biomarkers for Discriminating Subtypes and Functional States of Immune CellsSarah Lemire, Oana-Maria Thoma, Lucas Kreiss, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 29, 2017
Dynamics of Fukuoka Criteria and Patient Management in Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs) During Follow-UpBarbara Schellhaas, Francesco Vitali, Dane Wildner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Targeting of the transcription factor STAT4 by antisense phosphorothioate oligonucleotides suppresses collagen-induced arthritisKai M Hildner, Peter Schirmacher, Imke Atreya, et al.
Cell Cycle (Georgetown, Tex.)|February 18, 2010
Activation of epithelial STAT3 regulates intestinal homeostasisClemens Neufert, Geethanjali Pickert, Yan Zheng, et al.
Gut|June 28, 2023
Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel diseaseNanne K H de Boer, Melek Simsek, Berrie Meijer, et al.
Npj Biomedical Innovations|June 15, 2026
In vitro modeling of inflammatory bowel diseases using a newly developed immunocompetent colon epithelial monolayer co-culture modelImen Larafa, Roxana Zogorean, Adrian Buehler, et al.
European Journal of Gastroenterology & Hepatology|December 28, 2017
Effects of liver cirrhosis and patient condition on clinical outcomes in intrahepatic cholangiocarcinoma: a retrospective analysis of 156 cases in a single centerDaniel Jesper, Sabrina G Heyn, Barbara Schellhaas, et al.
Frontiers in Immunology|July 19, 2017
Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression ProfilesFriederike Fuchs, Daniela Schillinger, Raja Atreya, et al.
Pageof 74